Moderna CLO Vests RSUs, Sells Shares for Tax Purposes
Moderna, Inc.
Subscribe to track MRNA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Moderna CLO Vests RSUs, Sells Shares for Tax Purposes
Company: Moderna, Inc. (MRNA) Form: 4 | Filed: 2025-12-01 Significance: Low
Insider: Klinger Shannon Thyme Title: Chief Legal Officer | Relationship: Officer
Transaction: • Type: RSU Vesting & Tax Sale • Shares Acquired: 1,102 (Vesting) • Shares Sold: 534 (For Taxes) • Sale Value: ~$13,258 • Owned After: 28,738 shares
Key Insight: This is a routine, non-discretionary transaction related to the insider's compensation plan. The shares were sold automatically to cover tax liabilities from vesting RSUs, not as a discretionary market sale.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Moderna, Inc. (MRNA)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A routine and non-discretionary transaction where the Chief Legal Officer vested Restricted Stock Units (RSUs) and subsequently sold a portion of the shares to cover tax obligations.
- Market Impact: Negligible, due to the automated nature and small value of the transaction relative to the company's market capitalization.
Company Information
| Field | Value |
|---|---|
| Company | Moderna, Inc. |
| Ticker Symbol | MRNA |
| CIK | 0001682852 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | Klinger Shannon Thyme |
| CIK | 0001866132 |
| Title/Position | Chief Legal Officer |
| Relationship | Officer |
Transaction Details
This filing reports multiple transactions related to RSU vesting. The primary non-discretionary sale to cover taxes is detailed below.
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-26 |
| Transaction Code | F (Payment of tax liability by withholding securities) |
| Security Type | Common Stock |
| Shares Involved | 374 |
| Price Per Share | $24.75 |
| Total Value | $9,256.50 |
| Shares Owned After | 28,569 (following this specific transaction) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Total Value of Tax Sales | $13,258.10 |
| % of Market Cap | <0.001% |
| Total Shares Sold | 534 |
| % of Shares Outstanding | Not Available |
| Post-Transaction Ownership | 28,738 shares |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The total transaction value of ~$13k is insignificant against Moderna's market capitalization of $9.68 billion.
- Transaction Significance: The transactions are coded 'M' (exercise/vesting of derivative) and 'F' (tax withholding). These are automated events tied to executive compensation and do not reflect a discretionary investment decision by the insider. The impact on the market is negligible.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: These are pre-scheduled, non-discretionary transactions common for executive compensation. The small value and automated nature indicate no new information about the company's prospects.
Volume & Sentiment
- Expected Volume Impact: Negligible. The number of shares is too small to impact trading volume.
- Sentiment Indicator: Neutral. The market typically ignores routine tax-related sales from insiders.
Additional Context
Transaction Notes
- Special Circumstances: The filing details the vesting of RSUs and the automatic withholding of shares to satisfy tax obligations, as noted in Footnote F2. This is a standard procedure and not an open-market sale.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
